Amwill Health Care logo

Amwill Health Care financials and balance sheet

BSE: 544353Pharmaceuticals & BiotechnologySmall Cap

Last close ₹44.99up ₹1.24 (2.83%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹43.75.

52-week range of traded prices to 23 Oct 2026
₹28.91Low, 1 Apr 2026₹57.00High, 11 Nov 2025
Market cap
₹90 Cr3,120th largest listed
P/E
7.9
P/B
1.1
Dividend yield
1.11%
ROE
15.2%
Debt to equity
0.00
Volume, BSE
21,600

2 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Amwill Health Care annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹45 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue45
  2. Materials and goods−14
  3. Employee costs−8.4
  4. Other expenses−11
  5. Operating profit13
  6. Depreciation−0.5
  7. Other income+2.9
  8. Finance costs0.0
  9. Profit before tax15
  10. Tax−3.9
  11. Net profit11

What the company owns

  • Cash and bank₹47 Cr
  • Receivables₹21 Cr
  • Plant, investments and other assets₹18 Cr
  • Inventory₹1 Cr

What pays for it: net worth and liabilities

  • Net worth₹81 Cr
  • Other liabilities₹4 Cr
  • Owed to suppliers₹2 Cr

Profit and loss

Standalone, ₹ crore, years to March.Amwill Health Care half-yearly results

₹ croreMar 2025Filed 18 SepMar 2026Filed 30 May
Revenue from operations40.645.5
28.932.5
Materials and goods bought11.513.6
Employee costs7.28.4
Other expenses10.210.5
Operating profit before depreciation11.713.0
Operating margin28.7%28.6%
Materials, % of revenue28.4%29.9%
Employee costs, % of revenue17.7%18.5%
Other expenses, % of revenue25.2%23.1%
Depreciation and amortisation0.50.5
Operating profit after depreciation11.212.4
Other income0.72.9
Finance costs0.00.0
Profit before tax11.915.4
1.23.9
Net profit10.711.4
Net margin26.4%25.1%

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2025Filed 18 SepMar 2026Filed 30 May
69.280.6
Share capital20.020.0
Reserves49.260.6
Borrowings0.00.0
2.05.8
Liabilities due after a year0.30.3
Total assets71.586.7
49.414.9
22.171.8
Net debt−3.1−47.4
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2025Filed 18 SepMar 2026Filed 30 May
5.68.0
7.311.5
−4.5−1.6
Receivables−3.8−4.2
Inventories−0.1−0.3
Payables0.81.3
Other working capital−1.41.6
Tax paid−1.7−3.5
Capital spending0.70.6
Free cash flow4.87.4
−46.25.6
Cash from financing41.3−0.1
Dividends paid0.00.0
Shares issued41.30.0
Net change in cash0.713.5
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Standalone, ₹ per share, years to March.Amwill Health Care dividend history

₹ per shareMar 2025Filed 18 SepMar 2026Filed 30 May
Earnings per share₹6.63₹5.71
Diluted earnings per share₹6.63₹5.71
Dividend per share–₹0.50
Book value per share₹34.60₹40.28
Dividend payout–8.8%
Shareholder yield−29.9%0.0%
Market cap at the year end (₹ crore)13858

Ratios

Standalone, years to March.Amwill Health Care PE ratio and valuation

RatioMar 2025Filed 18 SepMar 2026Filed 30 May
Revenue growth–12.1%
Operating profit growth–11.5%
Net profit growth–6.4%
Earnings per share growth–−13.9%
15.5%15.2%
–−0.3 pts
From the net margin–−0.8 pts
From asset turnover–0.2 pts
From borrowing–0.3 pts
Return on capital employed16.2%15.4%
Cash conversion51.9%70.1%
Debt to equity0.000.00
Receivable days150168
Inventory days1822
Payable days3566
Cash conversion cycle, days133124
Working capital days153150
Asset turnover0.570.58
Assets per rupee of net worth1.031.06
Sales per rupee of plant35.1341.57
Capital spending to depreciation1.571.07

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
14.4%
Cash from operations against operating profit
61.6%
Measure3 years
Return on equity, average15.4%
Return on capital employed, average15.8%
Operating margin, average28.6%
Net margin, average25.8%
Asset turnover, average0.57
Cash conversion cycle, days, average129
Debt to equity, average0.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations8.00
Cash from investing5.56
Cash from financing−0.06
Capital spending0.59
Dividends paid0.00
Shares issued for cash0.00
Borrowings raised0.00
Borrowings repaid0.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2025Mar 2026
Receivables growth less revenue growthOur threshold 0 percentage points–12.90
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–32.01
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–2.17
Effective tax ratePublished threshold 17.16 per cent9.8625.67
Tax charged less tax paid, % of profitOur threshold 10 percentage points−4.442.99
A threshold marked as ours has no published figure; it is the line we read the check against.